FDA Investigator Constance L Richard

Constance L Richard has conducted inspections on 64 sites in 1 countries as of 10 Mar 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
64
Last Inspection Date:
10 Mar 2021
Investigator Role:
FDA Investigation Participant
Redica ID:
100002245
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Constance L Richard:
Aaron L Dunbar, Alecia L Marson, Ana Paulap Sandee, April L Brown, April L Young, Boun M Xiong, Brian E Thompson, Catherine M Vanderhoef, Charles L Zhou, Charles R Cote, RIC, Connie L Richard, Courtney R Tiegs, Dacia E Quick, Denise L Burosh, Diane T Reindl, Douglas J Snyder, Elias H Wachter, Eric A Breselow, Gordon T Wales, Grant M Ruis, Gregory R Brinsley, Gregory W Smith, Howard A Burmester, Ismael Garibay, Ivan E Reyes, Jacob W Reynolds, James K Ireland, Jamie R Thompson, Janis R Armedoriz, Jean M Bosenbecker, Jee Chung, PhD, Jeffry A Bernhardt, Jesse P Romenesko, Jessica L Barr, Joel D Hustedt, John P Hermann, Justin A Boyd, Kailas Nagaraj, Katherine A Clarke Girolamo, Kathryn M Mogen, Kathy Ac Girolamo, Kia L Copeland, Kibily D Dembele, Kimberly Lewandowski Walker, Kimberly W Destromp, Kristy E Zuroski, Lisa M Lopez, Lori B Wikstrom, Margaret M Lubbers Solberg, Marie A Fadden, Melissa J Holz, Michael E Cimaglio, Michele L Glendenning, Michelle J Glembin, Miles D Foster, Nibin Varghese, MS, Nicholas Z Lu, Nicole C Shokatz, Peter T Erlandson, Rafael A Kaup, Richard Jay Tucker, RS, Richard M Willey, Richard W Koller, Robert J Waldorf, Ross J Grigsby, Sandra A Hughes, Sandra D Wilson, Sandra Sejdinovic, Sarah A Palmer, Scott A Golladay, Scott B Laufenberg, Seth A Abbott, Shalonda C Clifford, Sharon K Thoma, PharmD, Soyinka S Eneng, Steven J Crowston, Tara C Singh, Tara M Humfeld, Tenzin Jangchup, Thomas W Garvin, Tomanik'e C Banks, Vaishali J Patel, William P Fournier, Ying Xin Fan, PhD

Constance L Richard's Documents

Publish Date Document Type Title
December, 2001 EIR Hack, Dr. Howard M., Clinical Investigator - EIR, 2001-12-19
August, 2000 FDA 483 Home Care Medical, Inc. - Form 483, 2000-08-02
November, 2001 FDA 483 Athea Laboratories Inc - Form 483, 2001-11-20
January, 2002 EIR Kurlanzik, Arthur E., M.D., Clinical Investigator - EIR, 2002-01-29
September, 2001 EIR Matheson Tri-Gas, Inc. - EIR, 2001-09-06
September, 2001 EIR Curia Wisconsin, Inc. - EIR, 2001-09-13
September, 2001 EIR Northland Laboratories - EIR, 2001-09-05
November, 2000 EIR Simon, Dr. Jeffrey S., Clinical Investigator - EIR, 2000-11-02
September, 2001 FDA 483 IKI Mfg Co., Inc - Form 483, 2001-09-21
February, 2002 EIR Salmeron, Dr. Betty Jo, Clinical Investigator - EIR, 2002-02-21
August, 2001 EIR Chemrite Copac, Inc. - EIR, 2001-08-21
August, 2001 FDA 483 Modern Products, Inc. - Form 483, 2001-08-09
September, 2000 FDA 483 Bajwa , Dr. Tanvir K. Clinical Investigator - Form 483, 2000-09-21
April, 2002 FDA 483 Cedarburg Pharmaceuticals, L.L.C. - Form 483, 2002-04-05
May, 2001 EIR Niazi, Imran K. - EIR, 2001-05-31
August, 2001 EIR Alliance Packaging Group, Inc. - EIR, 2001-08-20
September, 2000 FDA 483 Response Bajwa , Dr. Tanvir K. Clinical Investigator - Form 483R, 2000-10-10
December, 2001 EIR Kingchem Laboratories Inc. - EIR, 2001-12-06
April, 2002 EIR Curia Wisconsin, Inc. - EIR, 2002-04-05
May, 2000 EIR Silbar, Dr. Elliot C., Clinical Investigator - EIR, 2000-05-24
December, 2001 FDA 483 Hack, Dr. Howard M., Clinical Investigator - Form 483, 2001-12-19
September, 2000 EIR Bajwa , Dr. Tanvir K. Clinical Investigator - EIR, 2000-10-17
October, 2000 FDA 483 Hydrite Chemical Company - Form 483, 2000-10-17
May, 2001 FDA 483 Wisconsin Center for Clinical Research - Form 483, 2001-05-31
February, 2000 EIR Eurofins S-F Analytical Laboratories, Inc. - EIR, 2000-02-24
January, 2002 FDA 483 Kurlanzik, Arthur E., M.D., Clinical Investigator - Form 483, 2002-01-29
July, 2000 FDA 483 Wisconsin Pharmacal Company, LLC - Form 483, 2000-07-21
July, 2000 EIR Chemrite Copac, Inc. - EIR, 2000-07-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more